Antitumor studies - Part 2: Structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase

被引:28
作者
Ali, Hamed I. [2 ]
Tomita, Keiichiro [2 ]
Akaho, Eiichi [1 ]
Kunishima, Munetaka [1 ]
Kawashima, Yutaka [3 ]
Yamagishi, Takehiro [3 ]
Ikeya, Hisao [3 ]
Nagamatsu, Tomohisa [2 ]
机构
[1] Kobe Gakuin Univ, Fac Pharmaceut Sci, Life Sci Ctr, Chuo Ku, Kobe, Hyogo 6500045, Japan
[2] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Div Pharmaceut Sci, Okayama 7008530, Japan
[3] Taisho Pharmaceut Co Ltd, Med Res Labs, Omiya, Saitama 3038530, Japan
关键词
protein tyrosine kinase; flavin analog; AutoDock; SAR (structure-activity relationship);
D O I
10.1016/j.ejmech.2007.10.011
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Various analogs of flavins, 5-deazaflavins, and flavin-5-oxides were docked into the binding site of protein tyrosine kinase pp60(c-src), and some of them were assayed for their potential antitumor and PKC (protein kinase C) inhibitory activities in vitro. The results considering SAR (structure-activity relationship) revealed that the higher binding affinities obtained include compounds with the structure modifications on the flavin or 5-deazaflavin skeleton, namely, NH(2) or Ph (phenyl-) group at the C-2 position and so on. Computationally designed compounds 4a, 6a, b, 7, 11b, c, 12, 15, and 22c exhibited good docking results suggesting that they are potentially active antitumor agents. These compounds have 1-3 phenyl moieties, which are thought to be responsible for the planar aromatic fitting or electrostatic attraction onto the groove of the binding pocket. (c) 2007 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1376 / 1389
页数:14
相关论文
共 38 条
  • [1] AKAHO E, 2001, J CHEM SOFTWARE, V7, P103
  • [2] Akaho E, 1999, J CHEM SOFTWARE, V5, P147
  • [3] Antitumor studies. Part 1: Design, synthesis, antitumor activity, and AutoDock study of 2-deoxo-2-phenyl-5-deazaflavins and 2-deoxo-2-phenylflavin-5-oxides as a new class of antitumor agents
    Ali, Hamed I.
    Tomita, Keiichiro
    Akaho, Eiichi
    Kambara, Hiroto
    Miura, Shinji
    Hayakawa, Hiroyuki
    Ashida, Noriyuki
    Kawashima, Yutaka
    Yamagishi, Takehiro
    Ikeya, Hisao
    Yoneda, Fumio
    Nagamatsu, Tomohisa
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (01) : 242 - 256
  • [4] ALI HI, BIOORG MED IN PRESS
  • [5] SYNTHESIS OF 2-AMINO-2-DEOXO-5-DEAZAFLAVINS AND RELATED-COMPOUNDS
    AOYAGI, T
    YANADA, R
    BESSHO, K
    YONEDA, F
    ARMAREGO, WLF
    [J]. JOURNAL OF HETEROCYCLIC CHEMISTRY, 1991, 28 (06) : 1537 - 1539
  • [6] Modified AutoDock for accurate docking of protein kinase inhibitors
    Buzko, OV
    Bishop, AC
    Shokat, KM
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (02) : 113 - 127
  • [7] CHUG C, 1992, J NAT PRODUCTS, V55, P1529
  • [8] DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
    Ewing, TJA
    Makino, S
    Skillman, AG
    Kuntz, ID
    [J]. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2001, 15 (05) : 411 - 428
  • [9] Design, synthesis, and biological activity of non-amidine factor Xa inhibitors containing pyridine N-oxide and 2-carbamoylthiazole units
    Haginoya, N
    Kobayashi, S
    Komoriya, S
    Yoshino, T
    Nagata, T
    Hirokawa, Y
    Nagahara, T
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (21) : 5579 - 5586
  • [10] Hollosy Ferenc, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P173, DOI 10.2174/1568011043482124